Avanos Medical, Inc. to Present at the 2026 Citizens Life Sciences Conference
Rhea-AI Summary
Avanos Medical (NYSE: AVNS) will present at the 2026 Citizens Life Sciences Conference on March 11, 2026. CEO Dave Pacitti and CFO Scott Galovan will appear in a fireside chat at ~1:05 p.m. ET.
A live webcast will be available and later archived on the company's Investors webpage.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
AVNS slipped 0.85% while key peers were mixed: OFIX up 0.68%, BVS up 3.18%, SIBN up 2.95%, and CTKB modestly down. Only CTKB appeared in momentum scanners, suggesting today’s move was stock-specific rather than a broad medical devices trade.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 26 | Board nominations | Neutral | +0.9% | Cooperation agreement and nomination of two independent directors. |
| Feb 24 | Earnings results | Negative | -10.4% | 2025 results with goodwill impairment and weaker adjusted profitability. |
| Feb 16 | Earnings call setup | Neutral | +0.1% | Announcement of webcasted call to discuss Q4 and full‑year 2025. |
| Feb 03 | Reimbursement update | Positive | -0.4% | CMS maintained NOPAIN Act payments and added Game Ready in 2026. |
| Jan 20 | Strategic partnership | Positive | +0.1% | Co‑marketing agreement with Siemens Healthineers for pain management. |
News-driven moves have mostly aligned with sentiment, with a notable negative reaction to earnings and one divergence on favorable CMS reimbursement.
In the last few months, Avanos announced board refresh actions and a cooperation agreement with investor Bradley Radoff (Feb 26, 2026), modest 2025 financial results with a $77.0M goodwill impairment (Feb 24, 2026), and scheduled its earnings call on Feb 16, 2026. Earlier, CMS maintained NOPAIN Act payment and expanded device eligibility (Feb 3, 2026), and Avanos entered a strategic co‑marketing collaboration with Siemens Healthineers (Jan 20, 2026). Today’s conference appearance continues this pattern of investor- and clinician-facing communications.
Market Pulse Summary
This announcement highlights Avanos’ participation in the 2026 Citizens Life Sciences Conference, where leadership will join a fireside chat on March 11 at 1:05 p.m. ET. It extends a recent pattern of investor outreach following earnings, governance updates, and strategic partnerships. Investors may watch for any qualitative commentary on transformation efforts, cost savings targets, and portfolio strategy that could clarify or build on disclosures in recent 10-K and 8-K filings.
AI-generated analysis. Not financial advice.
A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.
About Avanos Medical, Inc.
Avanos Medical, Inc. (NYSE: AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to what matters. Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-2026-citizens-life-sciences-conference-302701642.html
SOURCE Avanos Medical
FAQ
When will Avanos Medical (AVNS) present at the 2026 Citizens Life Sciences Conference?
Who from Avanos Medical (AVNS) will speak at the March 11, 2026 conference?
How can investors watch the Avanos Medical (AVNS) presentation on March 11, 2026?
Will the Avanos Medical (AVNS) March 11, 2026 webcast be archived for later access?
What topics will Avanos Medical (AVNS) executives likely cover in the March 11, 2026 fireside chat?
